Cargando…
Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
Background: Pancreatic adenocarcinoma (PAAD) has a high degree of malignancy and a very poor prognosis, and the 5-year overall survival rate of patients is approximately 7%. To improve the prognosis of patients with PAAD, a more comprehensive and in-depth study of the pathogenesis of PAAD and the id...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798011/ https://www.ncbi.nlm.nih.gov/pubmed/36589239 http://dx.doi.org/10.3389/fmolb.2022.1096679 |